Skip to main content

IRT Reconiliation

 

  • IRT reconciliation : reconcile header data eg:subjectid,site id etc…

  1. IRT=interactive response or randomization Technology

  2. IRT helps clinical trial sponsors & site for manage the patient & drug supply logistics—-->because =ability to offer control & flexibility while increasing efficiency

   

IRT system⮜⮜⮜⮜⮜⮜⮜⮜⮜⮜⮜⮜⮜⮜⮜⮜
🠋⮟ manages 🠟
Randomization of patients ⮟ helps
into particular treatment ⮟
🠋🠋 ⮟
Patient receives sites
↙ 🠋 ↘ 🠟
 placebo drug combination schedule patient visit from
of drug initial screening until the
end of the treatment
                                                                                                                            


  1. IRT also helps to maintain blinding by making sure that specific roles in a study do not know the treatment that each patient is receiving

  2. CDM reconcile below list:                                                                                       

  • unticked

    Screening date

  • unticked

    Re-screening date

  • unticked

    Randomization number

  • What is IRT and How Does it Impact Clinical Trials?

  • What is Interactive Response Technology (IRT) or Randomization and Trial Supply Management System (RTSM)?

    An IRT system is known by many other names such as IVRS, IWRS, IXRS, RTSM but regardless of its name, the system delivers a wide range of features for managing patient enrollment and drug supply activities throughout the clinical trial lifecycle.

    What are the benefits of using IRT to Support Patient Enrollment into a Clinical Trial?

    Patient Enrollment, Randomization and Blind Protection – Utilizing the IRT to handle the enrollment and/or randomization automates the process and eliminates human error compared with manual methods. The system allows for complex protocol enrollment and randomization design and strictly controls sensitive information such as treatment arm and medication treatment assignments to maintain study blinding.

    How are Patients Randomized using IRT?

    The IRT will systematically randomize patients by assigning them to a treatment arm. There are several common methodologies which can be used such as central, subject stratified and/or site stratified randomization schemes. At the randomization visit, the IRT will assign the subject the appropriate treatment arm based on the programmed randomization methodology. The IRT will typically also assign the subject the appropriate medication kit which matches the randomized treatment arm.

  • What if I Choose not to use an IRT for Randomization?
    How does the IRT help protect the study blind?

    To truly appreciate how efficiently an IRT randomizes patients in a double-blind trial, just look at how it was done prior to the availability of IRT. When an IRT is not utilized, each entry on the patient randomization list is associated with a treatment type and matching kit number. The number is sealed in an envelope bearing a sequence number. A block of envelopes and the associated kits are sent to the investigational site where envelopes are chosen in sequence. The matching kit is then dispensed to the patient. While this method is reasonably efficient on an extremely small scale, it is slow and only works with simple randomization designs. Plus, it is subject to human error. When IRT handles randomization, the process is automated and centralized. It can accommodate complex stratification and randomization design that would not be possible with manual randomization. Randomization happens without human intervention, and therefore reduces human error. And, as with other aspects of study management, the system stores the data for easy tracking.  Automating the randomization and drug assignment process eliminates the need for paper envelopes or cards to be stored at the site where unblinded information could be compromised.

  • What are the benefits of using IRT for Supply Management?

    Individual kits stored at the depot and site are not labeled for particular patients. Instead, kits are assigned to patients when they arrive for their visit. So, shipments to sites only contain enough product to meet patient demand over a certain period, and resupplies are triggered when inventories hit a designated level. This process maximizes drug availability at the site, since products are only allocated to patients when they come in for visits and minimizes drug wastage. The IRT is able to tailor the supply provided to each site since it knows what patients are at each site, their treatment arms, and the visit schedule.

    Developing and maintaining an accurate forecast of product demand over the course of a clinical trial is essential to controlling costs. The IRT provides Supply Chain Managers with real-time updates of what is happening with patient enrollment and product inventory throughout the supply chain. This aids with budget preparation, prevents wastage that comes from stockpiling supplies, avoids the risk of stock-outs, and reduces emergency measures needed to replace expiring drugs.




Comments

Popular posts from this blog

Difference between central lab and Local Lab

 In the context of clinical trials, both central laboratories (central labs) and local laboratories (local labs) play essential roles in processing and analyzing biological samples. However, they differ significantly in their operations, advantages, and applications. Here’s a detailed comparison: ### Central Laboratory **Definition:** A central laboratory is a large, centralized facility that processes and analyzes samples from multiple sites participating in a clinical trial. These labs are usually equipped with advanced technology and staffed by highly trained personnel. **Key Characteristics:** - **Standardization:** Central labs offer standardized procedures and protocols, ensuring consistent and uniform testing across all samples. - **Quality Control:** They maintain stringent quality control measures, often accredited by recognized bodies (e.g., CAP, CLIA). - **Advanced Technology:** Equipped with state-of-the-art equipment and specialized assays, central labs can perform a w...

clinical data management in Clinical research

 Certainly! Below is an expanded and detailed discussion on clinical data management (CDM) that would cover approximately. --- # Clinical Data Management (CDM) in Clinical Research ## Introduction Clinical Data Management (CDM) is an integral part of the clinical research process, focusing on the collection, cleaning, and management of data generated during clinical trials. The primary objective is to ensure that data is accurate, complete, and reliable, supporting robust conclusions and regulatory submissions. This document provides a comprehensive overview of CDM, including its key components, tools, regulatory and ethical considerations, challenges, and future trends. ## Key Components of Clinical Data Management ### 1. Study Protocol Development The study protocol is the cornerstone of any clinical trial, outlining the study’s objectives, design, methodology, and statistical considerations.  #### Protocol Design - **Objective Setting**: Clearly defining the research questi...

study start up

  STUDY START UP/STUDY SET UP: eCRF(case report form): The case report form is a printed or electronic questionnaire for collecting data from study participants and reporting it to trial sponsors. The document is created specifically for each research project in accordance with the trial protocol, and recommendations of the Clinical Data Acquisitions Standards Harmonization (CDASH). They are developed by Clinical Data Interchange Standards Consortium to streamline industry-wide data exchange. Say, CDASH dictates dd/mm/yy format for collecting dates. (Read our article on CDISC standards to learn more.) Well-designed case report forms collect only data necessary for the particular study avoiding any redundancy. The fields to be filled in may include demographics (age, gender), basic measurements (height, weight), vital signs (blood pressure, temperature, etc.) captured at various time points, lab exams, medical history, adverse events, and more, based on the research requirements....